Nomogram to Predict the Survival of Chinese Patients with Alcohol-Related Liver Disease

Table 3

Multivariable analysis of ALD patients in the training cohort.

Variable	HR	95% CI	value
Relapse, n%	2.460	1.431–4.227	0.001
Cirrhosis, n%	3.875	1.036–14.500	0.044
AH, n%	0.937	0.572–1.534	0.796
Cancer, n%	2.888	1.625–5.132	<0.001
Ascites, n%	1.365	0.726–2.566	0.334
Encephalopathy, n%	1.458	0.879–2.419	0.144
HB	1.000	0.992–1.008	0.937
PLT	0.998	0.995–1.001	0.231
ALB	0.963	0.919–1.009	0.115
PT-INR	1.018	0.602–1.721	0.947
Na	0.985	0.961–1.009	0.208
MELD ≥21	2.051	1.029–4.088	0.041

value <0.05 was considered significant. AH, alcoholic hepatitis; HB, haemoglobin; PLT, platelet count; ALB, albumin; PT-INR, prothrombin time-International Standardization Ratio; MELD score, model for end-stage liver diseases score.